Inventor · disambiguated record
Thomas Kramps
Also filed as: KRAMPS THOMAS
28 granted patents·20 pending applications·570 citations·filing 2001–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0198US11965000B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·7 cites·30 claims
- 0298US11739125B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2021·Granted Aug 29, 2023·10 cites·15 claims
- 0398US11369694B2Rabies vaccineCUREVAC AG·Filed 2020·Granted Jun 28, 2022·11 cites·20 claims
- 0498US11266735B2Combination vaccineCUREVAC AG·Filed 2020·Granted Mar 8, 2022·40 cites·17 claims
- 0598US11034729B2Respiratory syncytial virus (RSV) vaccineCUREVAC AG·Filed 2018·Granted Jun 15, 2021·35 cites·20 claims
- 0698US10729761B2Vaccination in newborns and infantsCUREVAC AG·Filed 2019·Granted Aug 4, 2020·30 cites·20 claims
- 0798US10682426B2Rabies vaccineCUREVAC AG·Filed 2016·Granted Jun 16, 2020·30 cites·17 claims
- 0898US10596252B2Vaccination in newborns and infantsCUREVAC AG·Filed 2018·Granted Mar 24, 2020·30 cites·19 claims
- 0998US10588959B2Combination vaccineCUREVAC AG·Filed 2016·Granted Mar 17, 2020·30 cites·25 claims
- 1098US10172935B2Vaccination in newborns and infantsCUREVAC AG·Filed 2017·Granted Jan 8, 2019·33 cites·16 claims
- 1198US9688729B2Respiratory syncytial virus (RSV) vaccineCUREVAC AG·Filed 2016·Granted Jun 27, 2017·66 cites·21 claims
- 1297US10150797B2Respiratory syncytial virus (RSV) vaccineCUREVAC AG·Filed 2017·Granted Dec 11, 2018·39 cites·21 claims
- 1397US8968746B2Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationBAUMHOF PATRICK·Filed 2011·Granted Mar 3, 2015·70 cites·16 claims
- 1496US9623095B2Vaccination in newborns and infantsKALLEN KARL-JOSEF·Filed 2012·Granted Apr 18, 2017·74 cites·15 claims
- 1594US9226959B2Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvantKRAMPS THOMAS·Filed 2009·Granted Jan 5, 2016·57 cites·34 claims
- 1693US11690910B2Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCureVac SE·Filed 2019·Granted Jul 4, 2023·6 cites·20 claims
- 1792US12240873B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Mar 4, 2025·0 cites·46 claims
- 1892US2025129128A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2024·Application pending·0 cites
- 1991US12139513B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Nov 12, 2024·0 cites·44 claims
- 2091US2025345411A1Vaccination in newborns and infantsCureVac SE·Filed 2025·Application pending·0 cites
- 2190US12036277B2Vaccination with mRNA-coded antigensCureVac SE·Filed 2024·Granted Jul 16, 2024·0 cites·24 claims
- 2289US2024390478A1Vaccination in elderly patientsCureVac SE·Filed 2024·Application pending·0 cites
- 2388US12390520B2Vaccination in newborns and infantsCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·47 claims
- 2488US2023382954A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2023·Application pending·0 cites
- 2581US2025360196A1Combination vaccineCureVac SE·Filed 2025·Application pending·0 cites
- 2680US12337031B2Combination vaccineCUREVAC AG·Filed 2022·Granted Jun 24, 2025·0 cites·24 claims
- 2779US12083190B2Rabies vaccineCureVac SE·Filed 2022·Granted Sep 10, 2024·0 cites·18 claims
- 2878US2025345410A1Vaccination in newborns and infantsCureVac SE·Filed 2025·Application pending·0 cites
- 2976US2022401555A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2022·Application pending·0 cites
- 3075US11672856B2Vaccination in newborns and infantsCUREVAC AG·Filed 2020·Granted Jun 13, 2023·0 cites·31 claims
- 3175US2019151438A1VACCINATION WITH mRNA-CODED ANTIGENSCUREVAC AG·Filed 2019·Application pending·0 cites
- 3275US2023285594A1Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationCureVac SE·Filed 2022·Application pending·0 cites
- 3374US2021030866A1Vaccination in newborns and infantsCUREVAC AG·Filed 2020·Application pending·0 cites
- 3472US2021023199A1VACCINATION WITH mRNA-CODED ANTIGENSCUREVAC AG·Filed 2020·Application pending·0 cites
- 3570US11975064B2Vaccination with mRNA-coded antigensCureVac SE·Filed 2017·Granted May 7, 2024·0 cites·24 claims
- 3670US2017266268A1Vaccination in newborns and infantsCUREVAC AG·Filed 2017·Application pending·0 cites
- 3769US7375075B2Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereonUNI ZUERICH·Filed 2003·Granted May 20, 2008·2 cites·9 claims
- 3866US2016151474A1Vaccination in elderly patientsCUREVAC AG·Filed 2016·Application pending·0 cites
- 3964US2013295043A1Vaccination in elderly patientsKALLEN KARL-JOSEF·Filed 2012·Application pending·0 cites
- 4063US2020085942A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2019·Application pending·0 cites
- 4159US7252951B2Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereonUNIV ZUERICH·Filed 2002·Granted Aug 7, 2007·0 cites·15 claims
- 4258US2015118264A1Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCUREVAC GMBH·Filed 2013·Application pending·0 cites
- 4356US2015258214A1Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationCUREVAC GMBH·Filed 2015·Application pending·0 cites
- 4453US7049290B2Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereonUNIV ZUERICH·Filed 2001·Granted May 23, 2006·0 cites·4 claims
- 4553US2016250321A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2015·Application pending·0 cites
- 4652US11931406B2Flavivirus vaccineCureVac SE·Filed 2018·Granted Mar 19, 2024·0 cites·20 claims
- 4745US2015037326A1Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigenBAYER INNOVATION GMBH·Filed 2013·Application pending·0 cites
- 4844US2004209264A1New essential downstream component of the wingless signalling pathwayFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Kramps files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →